This section of the UPS Healthcare Supply Chain Vital Signs survey is focused on understanding the business priorities, supplier satisfaction and logistics challenges of pharmacies in the U.S., while providing valuable insights and implications for their clinical product suppliers, including pharma/biopharma suppliers and distributors. U.S. pharmacies are being challenged to treat unique patient needs in order to improve outcomes. In response, they are expanding patient care services for more complex specialty medications, such as advanced biologic drugs. To address the resulting requirements for special handling and compliance with government regulations, leading pharmacies are exploring new supply chain strategies.